ImmunomeInc Total Assets vs Net Working Capital Analysis
IMNM Stock | USD 14.94 0.23 1.56% |
ImmunomeInc financial indicator trend analysis is infinitely more than just investigating ImmunomeInc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ImmunomeInc is a good investment. Please check the relationship between ImmunomeInc Total Assets and its Net Working Capital accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmunomeInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in ImmunomeInc Stock, please use our How to Invest in ImmunomeInc guide.
Total Assets vs Net Working Capital
Total Assets vs Net Working Capital Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ImmunomeInc Total Assets account and Net Working Capital. At this time, the significance of the direction appears to have totally related.
The correlation between ImmunomeInc's Total Assets and Net Working Capital is 1.0. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Net Working Capital in the same time period over historical financial statements of ImmunomeInc, assuming nothing else is changed. The correlation between historical values of ImmunomeInc's Total Assets and Net Working Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of ImmunomeInc are associated (or correlated) with its Net Working Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Working Capital has no effect on the direction of Total Assets i.e., ImmunomeInc's Total Assets and Net Working Capital go up and down completely randomly.
Correlation Coefficient | 1.0 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Total Assets
Total assets refers to the total amount of ImmunomeInc assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in ImmunomeInc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Net Working Capital
Most indicators from ImmunomeInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ImmunomeInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmunomeInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in ImmunomeInc Stock, please use our How to Invest in ImmunomeInc guide.At this time, ImmunomeInc's Selling General Administrative is very stable compared to the past year. As of the 1st of June 2024, Enterprise Value is likely to grow to about 121.1 M, while Issuance Of Capital Stock is likely to drop about 29.1 K.
2021 | 2023 | 2024 (projected) | Depreciation And Amortization | 503K | 728K | 689.9K | Interest Income | 5K | 2.7M | 2.9M |
ImmunomeInc fundamental ratios Correlations
Click cells to compare fundamentals
ImmunomeInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ImmunomeInc fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 5.1M | 44.5M | 57.9M | 24.0M | 148.5M | 156.0M | |
Short Long Term Debt Total | 564K | 613K | 317K | 293K | 1.7M | 845.7K | |
Other Current Liab | 666K | 1.4M | 6.7M | 4.6M | 7.7M | 3.9M | |
Total Current Liabilities | 1.7M | 3.0M | 9.7M | 7.3M | 21.8M | 22.9M | |
Total Stockholder Equity | (35.6M) | 41.3M | 48.2M | 16.7M | 119.9M | 125.9M | |
Net Tangible Assets | (35.6M) | 41.3M | 48.2M | 16.7M | 19.2M | 10.0M | |
Property Plant And Equipment Net | 1.7M | 1.5M | 855K | 965K | 3.6M | 2.0M | |
Net Debt | (2.0M) | (39.2M) | (48.9M) | (20.0M) | (97.0M) | (92.2M) | |
Retained Earnings | (36.6M) | (54.4M) | (79.1M) | (116.0M) | (222.8M) | (211.7M) | |
Accounts Payable | 548K | 1.2M | 3.1M | 2.4M | 3.3M | 2.0M | |
Cash | 2.5M | 39.8M | 49.2M | 20.3M | 98.7M | 103.6M | |
Non Current Assets Total | 1.9M | 1.6M | 1.3M | 1.4M | 3.8M | 2.3M | |
Cash And Short Term Investments | 2.5M | 39.8M | 49.2M | 20.3M | 138.1M | 145.0M | |
Common Stock Shares Outstanding | 5.7M | 3.4M | 11.5M | 12.1M | 19.8M | 10.5M | |
Liabilities And Stockholders Equity | 5.1M | 44.5M | 57.9M | 24.0M | 148.5M | 156.0M | |
Non Current Liabilities Total | 39.0M | 142K | 12K | 62K | 6.8M | 9.9M | |
Capital Lease Obligations | 239K | 0.0 | 317K | 293K | 1.7M | 1.7M | |
Other Current Assets | 579K | 3.1M | 7.4M | 2.3M | 6.3M | 3.7M | |
Other Stockholder Equity | 927K | 95.7M | 127.3M | 132.7M | 342.7M | 359.8M | |
Total Liab | 40.7M | 3.2M | 9.7M | 7.4M | 28.7M | 15.9M | |
Net Invested Capital | (35.3M) | 42.0M | 48.2M | 16.7M | 119.9M | 125.9M | |
Property Plant And Equipment Gross | 1.7M | 1.5M | 3.9M | 681K | 7.5M | 7.9M | |
Total Current Assets | 3.1M | 42.9M | 56.6M | 22.6M | 144.7M | 151.9M | |
Accumulated Other Comprehensive Income | (38.9M) | (44.5M) | (57.9M) | 0.0 | 22K | 23.1K | |
Net Working Capital | 1.5M | 39.9M | 46.9M | 15.3M | 122.9M | 129.0M | |
Short Term Debt | 451K | 479K | 317K | 293K | 310K | 328.3K | |
Property Plant Equipment | 1.7M | 1.5M | 855K | 681K | 612.9K | 1.1M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as ImmunomeInc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmunomeInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in ImmunomeInc Stock, please use our How to Invest in ImmunomeInc guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for ImmunomeInc Stock analysis
When running ImmunomeInc's price analysis, check to measure ImmunomeInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmunomeInc is operating at the current time. Most of ImmunomeInc's value examination focuses on studying past and present price action to predict the probability of ImmunomeInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmunomeInc's price. Additionally, you may evaluate how the addition of ImmunomeInc to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is ImmunomeInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImmunomeInc. If investors know ImmunomeInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ImmunomeInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (17.58) | Revenue Per Share 0.427 | Quarterly Revenue Growth (0.56) | Return On Assets (0.15) | Return On Equity (1.55) |
The market value of ImmunomeInc is measured differently than its book value, which is the value of ImmunomeInc that is recorded on the company's balance sheet. Investors also form their own opinion of ImmunomeInc's value that differs from its market value or its book value, called intrinsic value, which is ImmunomeInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ImmunomeInc's market value can be influenced by many factors that don't directly affect ImmunomeInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ImmunomeInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImmunomeInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImmunomeInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.